Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Beyond Air Inc (XAIR)

Beyond Air Inc (XAIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 46,130
  • Shares Outstanding, K 36,039
  • Annual Sales, $ 0 K
  • Annual Income, $ -55,820 K
  • 60-Month Beta -0.18
  • Price/Sales 58.44
  • Price/Cash Flow N/A
  • Price/Book 1.84
Trade XAIR with:

Options Overview Details

View History
  • Implied Volatility 238.08% ( +7.38%)
  • Historical Volatility 77.39%
  • IV Percentile 85%
  • IV Rank 16.45%
  • IV High 1,178.61% on 01/18/24
  • IV Low 52.95% on 09/19/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 10
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 4,280
  • Open Int (30-Day) 4,525

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.51
  • Number of Estimates 2
  • High Estimate -0.49
  • Low Estimate -0.53
  • Prior Year -0.67
  • Growth Rate Est. (year over year) +23.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1300 +3.54%
on 04/25/24
1.7800 -34.27%
on 03/26/24
-0.5500 (-31.98%)
since 03/25/24
3-Month
1.1300 +3.54%
on 04/25/24
2.1700 -46.08%
on 02/12/24
-0.1600 (-12.03%)
since 01/25/24
52-Week
1.1300 +3.54%
on 04/25/24
6.3600 -81.60%
on 06/20/23
-4.5550 (-79.56%)
since 04/25/23

Most Recent Stories

More News
3 Healthcare Stocks Insiders Are Buying 

The healthcare industry is looking forward to double-digit growth, and these stocks the insiders are buying have analyst support too.

CNC : 75.60 (-0.77%)
XAIR : 1.1700 (-8.59%)
PGEN : 1.3950 (-1.76%)
Beyond Air, Inc. (XAIR) Reports Q3 Loss, Lags Revenue Estimates

Beyond Air, Inc. (XAIR) delivered earnings and revenue surprises of -2.38% and 100%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

XAIR : 1.1700 (-8.59%)
CTMX : 1.6000 (-1.84%)
Beyond Air® Schedules First Fiscal Quarter 2023 Financial Results Conference Call and Webcast

Call scheduled for Thursday, August 11th at 4:30 pm Eastern Time...

XAIR : 1.1700 (-8.59%)
Stock Indexes Slightly Lower as U.S. Q1 GDP Contracts More Than Expected

Morning Markets September S&P 500 futures (ESU22 ) this morning are down by -0.07%. Stock indexes recovered most of their overnight losses today in hopes that the pace of inflation throughout the world...

ESM24 : 5,080.25 (-0.53%)
CCL : 15.15 (+0.93%)
RCL : 138.14 (+1.03%)
NCLH : 19.40 (+0.05%)
NIO : 4.12 (-0.72%)
UPST : 22.86 (-1.12%)
ACN : 308.79 (-1.51%)
TSLA : 169.75 (+4.70%)
MO : 43.44 (+1.21%)
ORA : 63.66 (-2.05%)
PINS : 32.74 (-0.33%)
ORCL : 114.74 (-0.52%)
Beyond Air® Reports Financial Results for Fourth Fiscal Quarter and Year-End 2022

LungFit® PH received FDA approval for the treatment of term and near-term neonates with hypoxic respiratory failure on June 28, 2022 and the first phase of...

XAIR : 1.1700 (-8.59%)
Beyond Air’s LungFit® PH Receives FDA Approval to Treat Term and Near-Term Neonates with Hypoxic Respiratory Failure

First and only nitric oxide generator and delivery system indicated for the treatment of term and near-term neonates with hypoxic respiratory failure that...

XAIR : 1.1700 (-8.59%)
Beyond Air® Announces Fiscal Year End 2022 Financial Results Conference Call and Webcast Moved to Tuesday, June 28th

GARDEN CITY, New York, June 14, 2022 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company...

XAIR : 1.1700 (-8.59%)
3 Stocks to Avoid This Week

These investments seem pretty vulnerable right now.

ORCL : 114.74 (-0.52%)
XAIR : 1.1700 (-8.59%)
BLNK : 2.30 (-1.29%)
Beyond Cancerâ„¢ Announces the Appointment of Jedidiah Monson, M.D. to Chief Medical Officer

Dr. Monson is a board-certified radiation oncologist and brings over 25 years of clinical oncology experience to Beyond Cancer. Dr. Monson is a founding...

XAIR : 1.1700 (-8.59%)
Beyond Cancer, Ltd. Appoints Susan Howell Jones, CPA as Chief Financial Officer

Ms. Jones brings over 30 years of life science based financial experience to Beyond Cancer...

XAIR : 1.1700 (-8.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Beyond Air Inc. is a clinical-stage medical device and biopharmaceutical company. It is engaged in developing a Nitric Oxide Generator and Delivery System. The company's principal product is AirNOvent which is in clinical stage. Beyond Air Inc., formerly known as AIT Therapeutics Inc., is based in Garden...

See More

Key Turning Points

3rd Resistance Point 1.4983
2nd Resistance Point 1.4067
1st Resistance Point 1.3433
Last Price 1.1700
1st Support Level 1.1883
2nd Support Level 1.0967
3rd Support Level 1.0333

See More

52-Week High 6.3600
Fibonacci 61.8% 4.3621
Fibonacci 50% 3.7450
Fibonacci 38.2% 3.1279
Last Price 1.1700
52-Week Low 1.1300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar